Found 0 matching trials
Closed-loop DBS in Parkinson's Disease
NAClosed-loop DBS is an emerging neuromodulation pattern in Parkinson's disea...
Location
National Engineering Research Center of Neuromodulation
Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes
PHASE2Closed-loop strategy is composed of three components: glucose sensor to rea...
Location
Mount Sinai Hospital
Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format,
NAIn previous studies, the investigators tested the feasibility of a bi-hormo...
Location
Rijnstate Hospital
Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
NAAn unblinded, randomized, cross-over design with each patient participating...
Location
Sansum Diabetes Research Institute
Diabeloop WP7 : Crossover Evaluation of the Safety and the Efficacy of Artificial Pancreas Diabeloop (WP7)
NAThe study will be conducted in crossover trial, with two 12-weeks periods s...
Location
Centre Hospitalier Universitaire Jean Minjoz
Switch of AndroidAPS to Commercially Available AID Systems
NAThe aim of the study was to investigate the switch between open-source auto...
Status
Active Not Recruiting
Location
3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
NAPostprandial glycemic excursions are major determinants of overall glycemic...
Location
Montreal Clinical Research Institute
Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing
NAThe purpose of the study is to determine the effects of a novel, personaliz...
Location
Oregon Health and Science University
Closing the Loop in People with Type 1 Diabetes
NAThe main objective of this study is to determine whether home use of fully ...
Location
Addenbrooke's Hospital
Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China
NAThis is a 26-week randomized, free-living, open-label, two-arm, two-phase, ...